Richard H. Wilson
Belfast, NIR BT97AE, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Accuracy of glomerular filtration rate estimates among patients with cancer.
Journal: British journal of cancer
Published: March 13, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC).
Journal: BMC cancer
Published: February 11, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers.
Journal: BJC reports
Published: February 08, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.
Journal: Nature
Published: December 10, 2024
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: April 25, 2023
Trusting relationships between patients with non-curative cancer and healthcare professionals create ethical obstacles for informed consent in clinical trials: a grounded theory study.
Journal: BMC palliative care
Published: March 16, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
Journal: British journal of cancer
Published: October 31, 2022
Reply to A. Kurreck et al and M.S. Copur et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 22, 2022
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.
Journal: Clinical trials (London, England)
Published: January 27, 2022
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 20, 2021
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 13, 2021
Orthogonal MET analysis in a population-representative stage II-III colon cancer cohort: prognostic and potential therapeutic implications.
Journal: Molecular oncology
Published: August 03, 2021
Last Updated: 09/26/2026